Skip to main content

Table 1 Improvements resulted by the AERS implementation.

From: An adverse event capture and management system for cancer studies

#

Area of improvement

Estimated/actual improvement

1

Time spend for adverse event clarification between the clinical trial office staff and providers

Estimated 60% less inquiries to clinics for clarification

2

All ongoing AEs are being assessed every visit

The number of sponsor queries has decreased, which reduced the time needed to identify and complete missed and incomplete assessments.

3

Complete and accurate reporting of AEs

Staff spends less time to compile data from systems to complete needed attributes of an AE report. This allows more thorough and accurate reporting.

4

Timely reporting of AEs

As the complete and accurate AE report is easily available, the staff reports those in a timely manner as expected by the sponsors and regulatory bodies.

5

Complete reporting of the lab related AEs

Before AERS, the lab AE reporting was paper based with some potential missed lab-based AEs. Each lab AE had to be signed by the provider with proper association. After AERS, the research staff estimates that they are reporting 75% more lab-based AEs and providers just make the clinical significance determination and submit electronically.

6

Time saving and efficiency due to less number of queries.

We analyzed two studies and both of which have 10 subjects enrolled and the same investigational product, the time frame is from April 2008 to the present date. A) Study A that doesn't use AERS, had 106 queries out of which 73 were AE related (~69%). B) Study B that uses AERS, had 169 queries out of which 36 were AE related (27%)

  1. The information is collected from the anecdotal and quantitative responses of the clinical trial office staff and the clinic staff